MitchellWKrucoffMD
Cardiology • Durham, NCAdult Congenital Heart Disease
Professor, Medicine, Duke University School of Medicine
Are you Dr. Krucoff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 86 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
508 Fulton St Rm A3006
Durham, NC 27705Phone+1 919-620-4467
Summary
- Dr. Mitchell Krucoff, MD is a cardiologist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with Durham Veterans Affairs Medical Center and Duke University Hospital.
Education & Training
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 1983 - 1986
George Washington UniversityResidency, Internal Medicine, 1980 - 1983- George Washington University School of Medicine and Health SciencesClass of 1980
Certifications & Licensure
NC State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II) Start of enrollment: 2005 May 01
- HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt Start of enrollment: 2014 Feb 01
- LEADERS FREE II: BioFreedom™ Pivotal Study Start of enrollment: 2017 Feb 14
- Join now to see all
Publications & Presentations
PubMed
- Statistical considerations for cardiovascular clinical trials straddling the continuum of pandemic phases.Roseann White, Peter Lam, Nelson Lu, Xiaolu Su, Tracy Bergemann
Cardiovascular Revascularization Medicine. 2024-12-01 - Quantifying patients' preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudication.Shelby D Reed, Jessie Sutphin, Matthew J Wallace, Juan Marcos Gonzalez, Jui-Chen Yang
Vascular Medicine. 2024-12-01 - ACTION-ARC Pediatric and Adult Congenital Heart Disease Ventricular Assist Device Adverse Event Definitions-2023.Angela Lorts, Christina VanderPluym, Iki Adachi, Tanya Perry, Peta M A Alexander
ASAIO Journal. 2024-11-01
Press Mentions
New Data Registry Collects Evidence in Cardiogenic Shock PatientsOctober 19th, 2022
Another Study Finds No Evidence of Increased Long-Term Mortality with Paclitaxel-Coated DevicesOctober 10th, 2019
PCI Reduces Mortality After STEMI in Older AdultsApril 16th, 2019- Join now to see all
Professional Memberships
- Member
Other Languages
- French
